We are live on ! Find out more
RJA

Raymond James & Associates Portfolio holdings

AUM $164B
1-Year Est. Return 33.91%
This Fund
S&P 500
This Quarter Est. Return
-6.6%
1 Year Est. Return
+33.91%
3 Year Est. Return
+39.99%
5 Year Est. Return
+107.66%
10 Year Est. Return
+436.07%
AUM
$24.5B
AUM Growth
-$1.55B
Cap. Flow
+$503M
Cap. Flow %
2.05%
Top 10 Hldgs %
14.23%
Holding
2,483
New
111
Increased
1,136
Reduced
972
Closed
225

Sector Composition

Rank Sector Weight
1 Healthcare 9.12%
2 Technology 8.89%
3 Financials 8.43%
4 Consumer Staples 7.6%
5 Industrials 6.99%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FVD icon
251
First Trust Value Line Dividend Fund
FVD
$8.41B
$21.4M 0.09%
940,798
-111,197
-11% -$2.6M
LEA icon
252
Lear
LEA
$8.18B
$21.4M 0.09%
196,395
-32,813
-14% -$3.42M
IQV icon
253
IQVIA
IQV
$39.3B
$21.2M 0.09%
305,371
-3,033
-1% -$227K
VEU icon
254
Vanguard FTSE All-World ex-US ETF
VEU
$68.5B
$21.2M 0.09%
497,680
-41,789
-8% -$1.93M
GLD icon
255
SPDR Gold Trust
GLD
$141B
$21.1M 0.09%
197,502
+12,028
+6% +$1.3M
STEW
256
SRH Total Return Fund
STEW
$1.81B
$20.9M 0.09%
2,806,733
+69,533
+3% +$554K
VIG icon
257
Vanguard Dividend Appreciation ETF
VIG
$114B
$20.8M 0.09%
282,552
-4,766
-2% -$369K
FTA icon
258
First Trust Large Cap Value AlphaDEX Fund
FTA
$1.4B
$20.8M 0.08%
550,293
-245,483
-31% -$9.89M
XLY icon
259
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
$23.2B
$20.7M 0.08%
558,142
-135,362
-20% -$5.2M
DHR icon
260
Danaher
DHR
$144B
$20.7M 0.08%
361,439
+3,556
+1% +$210K
AET
261
DELISTED
Aetna Inc
AET
$20.6M 0.08%
188,502
+12,827
+7% +$1.48M
ALL icon
262
Allstate
ALL
$67.5B
$20.6M 0.08%
353,259
-161,459
-31% -$10.1M
NVO
263
Novo Nordisk
NVO
$209B
$20.5M 0.08%
756,938
+18,686
+3% +$529K
IMCB icon
264
iShares Morningstar Mid-Cap ETF
IMCB
$1.7B
$20.4M 0.08%
590,928
+12,032
+2% +$443K
NUE icon
265
Nucor
NUE
$62.1B
$20.2M 0.08%
538,339
-26,725
-5% -$1.15M
COF icon
266
Capital One
COF
$134B
$20.1M 0.08%
277,274
+6,047
+2% +$486K
EA
267
DELISTED
Electronic Arts
EA
$20.1M 0.08%
296,649
+183,372
+162% +$12.9M
SH icon
268
ProShares Short S&P500
SH
$897M
$20M 0.08%
111,192
+81,450
+274% +$14M
CTXS
269
DELISTED
Citrix Systems Inc
CTXS
$20M 0.08%
362,009
+20,632
+6% +$1.17M
SRE icon
270
Sempra
SRE
$54.8B
$19.9M 0.08%
411,152
+364,128
+774% +$17.9M
FEX icon
271
First Trust Large Cap Core AlphaDEX Fund
FEX
$1.61B
$19.9M 0.08%
475,269
-32,556
-6% -$1.45M
IJR icon
272
iShares Core S&P Small-Cap ETF
IJR
$112B
$19.9M 0.08%
372,580
+20,208
+6% +$1.15M
IONS icon
273
Ionis Pharmaceuticals
IONS
$9.4B
$19.7M 0.08%
486,519
+12,764
+3% +$661K
BDX icon
274
Becton Dickinson
BDX
$48.2B
$19.4M 0.08%
150,210
+29,009
+24% +$4.05M
ACH
275
Accendra Health
ACH
$214M
$19.4M 0.08%
608,093
-5,503
-0.9% -$187K

Similar funds

Raymond James & Associates's Q3 2015 Portfolio in Review

As of Q3 2015, Raymond James & Associates held 2,483 positions worth $24.5B, down 5.9% from $26.1B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Raymond James & Associates's Q3 2015 filing shows 111 new, 1,136 increased, 972 reduced and 225 closed positions. Its largest new stake was Camden Property Trust: 204,814 shares worth $15.1M. The largest sale was KRAFT FOODS GROUP INC COM STK (VA), an estimated $138M.

By sector, the portfolio is most concentrated in Healthcare at 9.1% of assets, down from 9.2% a quarter earlier, followed by Technology and Financials.

  • Raymond James & Associates's largest Q3 2015 buy was Camden Property Trust: 204,814 shares worth $15.1M.
  • Raymond James & Associates added most to ExxonMobil in Q3 2015, an estimated $88.7M increase.
  • Raymond James & Associates's biggest Q3 2015 reduction was TotalEnergies, cutting an estimated $63.3M.
  • Raymond James & Associates fully exited KRAFT FOODS GROUP INC COM STK (VA) in Q3 2015, selling an estimated $138M.
  • Raymond James & Associates's ten largest holdings make up 14% of its $24.5B portfolio in Q3 2015.
  • Raymond James & Associates opened 111 new positions and closed 225 in Q3 2015.
  • Raymond James & Associates's portfolio value fell 5.9% quarter-over-quarter to $24.5B.

Based on Raymond James & Associates's 13F filing for Q3 2015, filed 13 Nov 2015.